Abstract:Transcriptional enhancers orchestrate cell-type-specific gene expression programs, but how they convey signal-activated transcriptional responses remains poorly understood. Here, the cell-lineage-specific transcription factor FoxA1 is shown to both facilitate and restrict the androgen receptor to act on distinct classes of enhancers. Lowered levels of FoxA1, such as those found in prostate cancer, can reprogram the hormonal response by causing a switch in androgen receptor binding to a set of pre-established, functional enhancers that are marked by enhancer-derived non-coding RNAs (eRNAs). This work points to the existence of a large repository of active enhancers that can be tuned to allow alternative gene expression programs in normal cell development and in disease progression. Mammalian genomes are populated with thousands of transcriptional enhancers that orchestrate cell-type-specific gene expression programs1,2,3,4, but how those enhancers are exploited to institute alternative, signal-dependent transcriptional responses remains poorly understood. Here we present evidence that cell-lineage-specific factors, such as FoxA1, can simultaneously facilitate and restrict key regulated transcription factors, exemplified by the androgen receptor (AR), to act on structurally and functionally distinct classes of enhancer. Consequently, FoxA1 downregulation, an unfavourable prognostic sign in certain advanced prostate tumours, triggers dramatic reprogramming of the hormonal response by causing a massive switch in AR binding to a distinct cohort of pre-established enhancers. These enhancers are functional, as evidenced by the production of enhancer-templated non-coding RNA (eRNA5) based on global nuclear run-on sequencing (GRO-seq) analysis6, with a unique class apparently requiring no nucleosome remodelling to induce specific enhancer–promoter looping and gene activation. GRO-seq data also suggest that liganded AR induces both transcription initiation and elongation. Together, these findings reveal a large repository of active enhancers that can be dynamically tuned to elicit alternative gene expression programs, which may underlie many sequential gene expression events in development, cell differentiation and disease progression.

FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription.

Reprogramming Transcription by Distinct Classes of Enhancers Functionally Defined by Erna.

Histone H3 Lysine 4 Monomethylation Modulates Long-Range Chromatin Interactions at Enhancers

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

FOXN Transcription Factors: Regulation and Significant Role in Cancer

Foxc1 Establishes Enhancer Accessibility for Craniofacial Cartilage Differentiation.

Identification of Transcription Factor-Binding Sites in the Mouse FOXO1 Promoter

Histone Modifications at Human Enhancers Reflect Global Cell-Type-specific Gene Expression

Transcriptional regulation of the thymus master regulator Foxn1

Locus Co-Occupancy, Nucleosome Positioning, and H3K4me1 Regulate the Functionality of FOXA2-, HNF4A-, and PDX1-bound Loci in Islets and Liver.

FOXD3 controls pluripotency through modulating enhancer activity.

Foxg1 and companions: not only transcription factors

Redirecting the pioneering function of FOXA1 with covalent small molecules

DNA demethylation switches the drivers of Foxp3 expression to maintain regulatory T cell identity

Mapping cell type-specific transcriptional enhancers using high affinity, lineage-specific Ep300 bioChIP-seq

Foxg1 bimodally tunes L1 -mRNA and -DNA dynamics in the developing murine neocortex

Foxp3 Enhancers Synergize to Maximize Regulatory T Cell Suppressive Capacity.

FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer

Temporally discordant chromatin accessibility and DNA demethylation define short and long-term enhancer regulation during cell fate specification

A Systematic Approach Identifies Foxa1 As A Key Factor in the Loss of Epithelial Traits During the Epithelial-To-Mesenchymal Transition in Lung Cancer

Forkhead Box Family Transcription Factors As Versatile Regulators for Cellular Reprogramming to Pluripotency.